GL
Gary A Lyons (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.3M of NBIX (15,000 sh × $152.61, as filed), executed Dec 3 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.2M
shares × price, as filed
Last traded
Aug 18
Filed Aug 19
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$543K8,600 sh across 3 lots
Exec Aug 17
Filed Aug 19 · 4:05 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $329K
8,000 sh × $41.07
Exec Apr 14
Filed Apr 16 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. View filing → $2.3M
15,000 sh × $152.61
Exec Dec 3 2025
Filed Dec 4 2025 · 5:30 PM ET